Wrong Number

Wrong Number

A day doesn’t go by without the financial services or pharmaceutical industry taking it on the chin. Both were summarily called to the carpet this week for their profligate behavior — Wall Street for bonuses and big pharma re: drug cost givebacks. Yet relative scant attention is given to the one industry whose transgressions may […]